Peripheral blood monorytes can be induced by stimuli such as bacterial lipopolysaccharide (LPS) to secrete an array of cytokines. We have studied the effects of interleukin 7 (IL 7) on human peripheral blood mononuclear cells (PBMC) and found that IL-7 is a relatively potent inducer of IL6 secretion . 11,6 protein levels were determined either by the B9 hybridoma growth factor assay or by enzyme-linked immunosorbent assay, and mRNA for IL-6 was analyzed by Northern hybridization . Detailed examination revealed that, among PBMC, monocytes, rather than lymphocytes, were secreting IL-6 in response to IL-7. In contrast to the low concentrations of IL-7 required to stimulate T cell growth and differentiation (as low as 0
Aprimary function of peripheral blood monorytes is the regulated synthesis and secretion of an array ofbiologically active molecules including enzymes, plasma proteins, and cytokines. Monocyte-derived cytokines include IL1a, 11,113, 11,6, 11,8, and TNF-a, all of which have broad immunoregulatory properties and are central to the host response to infection (1-4). Microbial products such as LPS and peptidoglycan are the most effective inducers of cytokine secretion by monorytes . More recently, cytokines themselves have been demonstrated to regulate monocyte rytokine synthesis (5-13). In particular, IL1a, IL10, TNF-ci, TGF-(3, IFN-'y, granulocyte/macrophage CSF (GM-CSF)t, and 11,3 have all 1 Abbreviations used in this paper. GM-CSF, granulocyte/macrophage colonystimulating factor; LAK, lymphokine-activated killer cell. 923 been shown to stimulate some aspect of monocyte rytokine secretion, either acting alone or in combination with other stimuli . Conversely, 114 has potent antagonistic effects on the induction of monocyte activation, including both rytokine secretion and respiratory burst activity (4, 8, 9, (14) (15) (16) (17) .
IL7 is a stromal cell-derived cytokine that has a number of effects on lymphocytes . IL7 stimulates the growth ofpre-B cells, thymocytes, and mature T cells, and enhances the generation of CTL and lymphokine-activated killer cells (18) (19) (20) (21) (22) (23) (24) . Receptors for IL-7 have also been demonstrated on myeloid cells (25) , however, until now, no activity for IL7 on monorytes/macrophages or neutrophils has been reported. In this study, we found that IL7 has potent effects on cells of the monocytic lineage. 11,7 stimulated the secretion of cytokines including IL-6, ILIot, IL1#, and TNF-ot from purified human peripheral blood monocytes and induced monocyte/macrophage tumoricidal activity. These results implicate 1177 as an important regulator of inflammation by inducing the secretion of cytokines that are central to the inflammatory process.
Materials and Methods
Preparation ofCells and Cell Cultures. PBMC were isolated from heparinized blood by centrifugation over Ficoll-Hypaque. Monocytes were enriched by counter current elutriation of PBMC followed by adherence to plastic. Briefly, elutriator enriched monocytes were cultured at 2 x 10 5 cells in 16-mm wells (3524; Costar, Cambridge, MA) in 1 ml of culture medium . After 90 min of incubation at 37°C, nonadherent cells were removed by gentle washing and replaced with fresh culture medium . The elutriated cells were 90-95% monocytes by microscopic examination of Giemsa-stained cytospin preparations and 80-85% CD14+ by flow cytometry. Culture medium consisted of low endotoxin RPMI 1640 (Whittaker M.A . Bioproducts, Walkersville, MD) supplemented with 10% low endotoxin FCS (Cellect Gold ; Flow Laboratories, McLean, VA), 50 U/ml penicillin, 50 ug/ml streptomycin, and 5 x 10 -5 M 2-ME .
Cytokines. Cytokine preparations used in this study were selected on the basis of their low endotoxin content . All cytokines contained <1 pg of endotoxin per microgram of protein, except IIAcx which contained 3 pg, as determined by the Limulus amebocyte lysate assay (Whittaker M.A . Bioproducts) . IL7 was purified from Escherichia coli expressing a human 11,7 cDNA, as described previously (23) . IL7 had a specific activity of 3 x 10' U/ug in the murine pre-B cell assay (18) . IIAca and IL10 were purified from E. coli expressing human IL la or 11,10 cDNAs as described previously (26) and had specific activities of 1.9 x 106 and 2.2 x 10 6 U/ ug, respectively, in the thymocyte costimulation assay. I1'4 was purified from the supernatant of yeast cells expressing a human 11,4 cDNA and had a specific activity of 10^U /hg in a B cell comitogenesis assay (27, 28) . GM-CSF was purified from yeast cells expressing a human GM-CSF cDNA and had a specific activity of 5 x 10" U/hg in a human bone marrow proliferation assay.
Other Reagents. LPS from Salmonella typhimurium was purchased from Difco Laboratories Inc. (Detroit, MI) and used at 10 ug/ml. 11,6, ILlox IL1O, and TNFtx Assays. 11,6 bioactivity in culture supernatants was determined using the IL6-dependent B9 hybridoma growth factor assay (3). Briefly, thrice-washed B9 cells were added to serial dilutions of test supernatants in 0.2 ml of RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (HyClone Laboratories, Logan, UT) in 96-well flatbottomed plates (Costar) . Samples were assayed in duplicate. After 3 d, cell proliferation was assessed by ['H]thymidine (1 P.Ci/well) incorporation during a 6-h incubation . One unit of 11,6 is defined as the amount required for half-maximal stimulation of B9 proliferation. 11,6 was also assessed by an ELISA specific for human IL6. ELISA plates (Corning Glass Works, Corning, NY) were coated overnight at 4°C with 5 Ftg/ml of a murine mAb against human IL6. After blocking with a 5% solution of nonfat dry milk in PBS, test supernatants were serially diluted in PBS with 10% goat serum and incubated for 1 h at room temperature. Plates were washed and a rabbit antiserum raised against human 11,6 was added at 1:1,000 dilution in PBS/20% goat serum. After a further hour at room temperature, a horseradish peroxidase coupled goat anti-rabbit Ig (Sigma Chemical Co., St . Louis, MO) at 1:2,000 dilution in PBS/5% nonfat dry milk was added. After washing, the substrate Urla concentrations in test supernatants were also determined by ELISA. The II.1tx ELISA was identical to the 11,6 ELISA except that the coating mAb and second step rabbit antiserum were specific for human IIAce instead of IL6.
TNF-a and IL10 concentrations were determined using commercial ELISA kits (R & D Systems), as per the manufacturers protocol .
Northern Blot Analysis ofIL6 mRNA . Total cellular RNA was isolated as previously described (29) . 10 Rg of RNA was separated on 1% agarose/6% formaldehyde gels, transferred to nylon filters (Hybond; Amersham Corp., Arlington Heights, IL) and stained by methylene blue to ensure equal loading in each lane. After prehybridization, the filters were hybridized at 63°C in a buffer containing 5x SSC/10x Denhardt's/50% formamide for 18 h, at which time the filters were washed first in 1 x SSC/0.1% SDS, then 0.lx SSC/0.1% SDS, at 68°C. The filters were then subjected to autoradiography.
An antisense RNA transcript was synthesized from a human 111,6 cDNA using '1P-UTP (Amersham Corp .) and T3 RNA polymerase (Promega Biotec, Madison, WI) and was used for probing IL6 mRNA from Northern blots.
Monocyte-Macrophage-Mediated TumoricidalAssay. The ability of monocytes/macrophages to lyse A375 human melanoma cells was assessed as previously described (30, 31) . , Mountain View, CA) at 2 ml per tube in the presence or absence of various stimuli, as previously described (32, 33) . After 24 h of incubation at 37°C in a humidified atmosphere of 5% COZ in air, plasma was separated by centrifugation at 700 g for 10 min and filtered through 0 .45-AM millipore filters. Cytokine levels were determined by ELISA, as described above.
Results

IL7
Stimulates 11,6 Secretion by Human Peripheral BloodMonocytes. Initially, we observed that supernatants from PBMC cultures stimulated with 11,7 for 36 h contained elevated levels of IL-6 compared to control noncytokine supplemented cultures (Table 1) . Culture supernatants were assessed for the presence of IL-6 by the ability to cause the proliferation of the IL-6-dependent B9 hybridoma cell line (3). Because PBMC, in particular monocytes, are exquisitely sensitive to endotoxin with regards to IL6 secretion, all reagents used in this study were selected for their low endotoxin levels . In addition we found that heating IL-7 to 100°C for 30 min totally abolished its ability to induce IL-6 secretion by PBMC, whereas heating of LPS had no effect on its activity (data not shown) .
Monocytes, T cells, and B cells have all been shown to secrete IL6, though monorytes appear to represent the major cellular source in human peripheral blood (3, 34) . To determine what cells were being stimulated by IL-7 to secrete IL6, we separated PBMC into populations enriched for monocytes and T cells (Exp. 1), or monorytes and lymphocytes (Exp. 2), as shown in Table 1 . PBMC were subjected to counter current elutriation and divided into lymphocyte-and monocyte-enriched fractions, based upon microscopic examination of Giemsa-stained cytospins . In Exp . 1 the lymphocyte fraction was further enriched for T cells by E-rosetting, and in Exp. 2 the lymphocyte fraction was further depleted of monorytes by two cycles of plastic adherence. The monocyte fraction after further enrichment by plastic adherence contained 90-95% monorytes by examination of Giemsastained cytospins and 85-90% CD14+ cells by flow cytometry whereas the lymphocyte fraction contained <1% CD14+ cells. The data in Table 1 demonstrate that after stimulation with IL7, IL1a, IL10, or LPS, the vast majority of IL-6 was secreted by the monocyte-enriched population, with little activity coming from the lymphocyte or T cell populations . However, T cells did secrete high levels of IL-6 after 5 d of incubation with the combined stimulus of PMA plus PHA, as previously reported (reference 34 ; data not shown), thus confirming the capability of T cells to secrete IL-6. Table 1 also indicates that LPS was the most potent stimulus for monocyte IL-6 production, followed by IL-7, IL 1a, and IL1 (3 . 11,7 Stimulates IL6 mRNA in Monocytes. To examine the effects of 11,7 on IL-6 gene expression, we assessed IL-6 mRNA levels by Northern analysis after culturing monorytes with Monocyte-and lymphocyte-enriched cell populations were isolated from PBMC by elutriation . T cells were further enriched from lymphocytes by E-rosetting and monocytes enriched by plastic adherence, as described in Materials and Methods . PBMC, lymphocytes, and T cells were cultured at 106/ml and monorytes at 2 x 105/ml in the presence of various stimuli for 36 h . Supernatants were collected and assessed for IL-6 bioactivity in the B9 assay (3) . 925 Alderson et al.
various stimuli for 4 h. Fig. 1 demonstrates that IL7, IILla, IIL10, and LPS all stimulated significant IL-6 mRNA accumulation in monocytes, whereas in cells cultured in medium alone, IL-6 mRNA was not detectable. In agreement with our IL6 secretion data (Table 1) , the level of IL-6 mRNA expression induced by IL-7 was greater than that induced by IL1(3, though slightly less than that induced by LPS. Dose-Response of 11,7 Induction of IL6 Secretion . IL7 and IL1/3 were compared for their ability to induce IL-6 secre- Figure 1 . 110 induces IL-6 mRNA in monorytes. Monocytes were cultured with medium alone, ILla (100 ng/ml),11,10 (100 ng/ml), IL7 (100 ng/ml), or LPS (10 ug/ml) . After 4 h RNA was extracted and Northern analysis was performed with an 11,6 antisense RNA transcript probe . J tion by monorytes . IL6 levels were assessed by either the B9 hybridoma growth factor assay ( Fig. 2 A) or by ELISA (Fig.  2 B) . IL-7 induced significant IL6 production when used at concentrations of 10 ng/ml or greater, though optimal IL-7 activity was observed at 100 ng/ml. In contrast, IL10 had a significant effect on 11,6 secretion at 0.1 ng/ml, in agreement with previously published data (7) . However, optimal concentrations ofIL7 induced -10-fold higher levels of IL-6 than optimal concentrations of IL10 (Fig. 2) . Identical results were obtained when 11,6 was assayed by either B9 assay or by ELISA. Monocytes Are Less Sensitive to 11,7 than Are T Lymphocytes. We have previously shown that IL7 costimulates the proliferation ofhuman T cells and enhances CTL generation at concentrations as low as 0.1 ng/ml (21, 23) . To directly compare the concentrations of IL-7 required to stimulate T cells versus monocytes, we used the same preparation of IL-7 and compared its ability to either induce IL-6 secretion by monocytes or enhance CTL generation in human MLC ( Table  2 ). As shown above (Fig. 2) , 10 ng/ml or more of IL-7 was required for the induction of IL-6 secretion and the optimal effect was seen at 100 ng/ml. In contrast, as little as 0.1 ng/ml of IL7 could enhance CTL generation and maximal effects were seen at 10 ng/ml (Table 2) . Thus, CTL precursors appear to display a -100-fold greater sensitivity to IL-7 than monocytes.
Kinetics ofIL6 Induction by 11,7. Monocytes were stimu- lated with optimal concentrations of IL-7, IL1(3, or LPS and supernatants were collected at various time points and assayed for IL-6 activity. As shown in Fig. 3 , low levels of IL6 were detectable in the supernatants of IL-7, IWO, or LPSstimulated monorytes as early as 2 h after the initiation of culture. IL-6 was not detected in nonstimulated cultures at any time point (data not shown) . All three stimuli showed similar kinetic profiles of IL-6 induction with optimal levels of IL-6 being detected within 24 h. Again 11,7 was found to be a more potent inducer of IL-6 secretion than 11,10. 11,4 Inhibits the Ability of 11,7 to Induce IL6 Secretion and IL6 mRNA. 11,4 has been reported to inhibit both monocyte function and cytokine secretion induced by mitogenic stimuli such as LPS (4, 8, 9, 14-17) . We initially observed that the addition of 1174 to PBMC cultures inhibited the ability Figure 3 . Kinetics of 11,6 production by monocytes. Monocytes were stimulated with 11,7 (100 ng/ml), 11,10 (100 ng/ml), or LPS (10,ug/ml) for various time periods and supernatants collected and assayed for 11,6 bioactivity in the B9 assay. Monocytes were cultured with IL-7 (100 ng/ml) or LPS (10 pg/ml) either in the presence or in the absence of IL-4 (50 ng/ml in Exp. 1 and 100 ng/ml in Exp . 2) . Supernatants were collected after 36 h and assayed for IL-6 bioactivity .
of 11,7 to induce lymphokine-killer cell (LAK) activity (23) .
To determine whether IL-4 could also inhibit the production of IL-6, we cultured purified monocytes with 1177 or LPS, either alone or in the presence of IL 4 . IL4 treatment alone was unable to induce IL-6 secretion by monocytes, however IL-4 was found to markedly inhibit the ability of either IL-7 or LPS to promote IL6 secretion (mean of 88% and 74% inhibition, respectively) ( Table 3) . Suppression of IL-7-induced Figure 4 . 11,4 inhibits the ability of IL7 and LPS to induce IL6 mRNA in monocytes . Monocytes were cultured with medium, IL7 (100 ng/ml), or LPS (10 tag/ml) either with (+) or without (-) IL4 (100 ng/ml) . After 4 h RNA was extracted and Northern analysis was performed with an 11,6 antisense RNA transcript probe .
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IL6 secretion could be seen at concentrations of 1174 as low as 0 .1 ng/ml (data not shown) . The inhibitory effects of ILA on IL6 secretion were also apparent at the mRNA level (Fig .  4) . The addition of 114 to monocytes stimulated with either IL-7 or LPS significantly downregulated IL-6 mRNA .
11,7 induces IL1a, 11,1,8, and TNF-a Secretion by Monocytes. We next investigated the ability of IL-7 to induce the secretion of other cytokines by monocytes, namely IL1a, IL10, and TNF-a . Monocytes were cultured for 36 h with various concentrations of IL7 or 10 hg/ml of LPS, and supernatants were collected and assessed for the presence of IL 1a, IL 1(3, IL6, and TNF-a by cytokine-specific ELISAs . Supernatants from monocytes cultured with medium alone or up to 10 ng/ml of IL-7 contained nondetectable levels of all four monokines (Table 4) . However, IL-7 at 100 ng/ml or greater induced significant secretion of IL1a, IL1O, 11,6, and TNF-ce by monocytes . Optimal concentrations of IL-7 induced >100-fold increases in production of all three cytokines . 11,7 Induces Monocyte/Macrophage Tumoricidal Activity.
Monocytes can be stimulated in vitro by LPS or certain cytokines, such as GM-CSF, to become cytotoxic for selected tumor cell lines (30, 31) . As a result, we assessed the ability of IL-7 to promote monocyte/macrophage tumoricidal activity against the A375 human melanoma cell line. Table 5 demonstrates that IL7 significantly enhanced monocyte/macrophage tumoricidal activity, inducing a mean of 43% cytotoxicity in three experiments compared to 55% and 63% with GM-CSF and LPS-cultured monocytes, respectively. 11,7 Induces 11,6 Secretion in Whole Blood Cultures. Recently, the ability of LPS to induce 11,6 and TNF-a in whole blood cultures was described (32, 33) . This culture system more closely resembles in vivo conditions than isolated PBMC or monocytes and avoids any effects that may be attributed to cell preparation, culture medium, FCS or adherence to plastic. Therefore, we assessed the ability of cytokines, namely IL-7 Table 4 . IL-7 Induces Monocytes to Secrete IL-la, IL-1,8, and TNF-a in Addition to Cytokine production Monocytes were incubated with the indicated concentration of rIL-7 or LPS (10 Rg/ml) and supernatants collected after 36 h . Culture supernatants were assayed for IL-la, IL-113, IL-6, and TNF-a by specific ELISAs .
IL-7
IL-la IL-1/3 IL-6 TNF-a ng/ml pg/ml 0 Percent cytotoxicity IL-7 (100 ng/ml) was compared to, GM-CSF (100 ng/ml) and LPS (10 j ug/ml) for its ability to induce monoryte/macrophage tumoricidal activity as described in Materials and Methods. and 11,10, to stimulate IL1a,11,10, IL6, and TNF-oi production in whole blood cultures . As shown in Table 6 , cytokines were not detected in whole blood cultured for 24 h in the absence of a stimulus. As previously reported, LPS was a potent stimulus for cytokine secretion in whole blood cultures .
In addition, high levels of IL-6 were detected in the plasma from whole blood stimulated with IL-7 or ILlO. However, in contrast to purified monocyte cultures where IL-7 was almost as potent a stimulus as LPS, IL-7 was a relatively poor stimulus for rytokine production in whole blood. IL-7 also induced IL1a and ILl/3 secretion in whole blood, though TNF-a levels were only marginally above background .
Interleukin 7 has a number of biological effects on lymphocytes and lymphocyte precursors, including stimulating the growth of pre-B cells, thymocytes, and mature T cells (18) (19) (20) (21) (22) (23) (24) . In the experiments reported herein, we demonstrate that purified rIL7 also has potent effects on human peripheral blood monocytes. When IL7 was added to PBMC or Whole blood cultures were supplemented with IL-1/3 (100 ng/ml), IL-7 (100 ng/ml), or LPS (10 Ag/ml) . After 24 h, plasma was isolated and assessed for the presence of IL-1cr, IL-1/3, IL-6, and TNF-cr by specific ELISAs .
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Effect of Interleukin 7 on Human Monocytes purified monorytes, it was found to stimulate the secretion of high levels of IL6, IL1a, ILls, and TNF-a. In addition, IL7 was a strong inducer of monocyte/macrophage-mediated lysis of the A375 human melanoma cell line. The activity of IL7 on monoryte rtokine secretion resembles that of bacterial endotoxin, though we believe that our results are not due to endotoxin contamination of our rtokine preparations for the following reasons. First, our cytokines are extensively purified and particular preparations selected on the basis of their low endotoxin content (usually <1 pg per Wg ofprotein). Second, heating of IL7 totally ablated its ability to stimulate IL6 secretion and IL-6 mRNA, whereas heating ofLPS had no effect on its activity on monocytes (data not shown) . Finally, IL7, at concentrations up to 11~g/ml, was unable to induce IL6 secretion by the THP-1 monocytic cell line whereas LPS is a potent inducer of IL6 secretion by these cells (data not shown) .
Dose-response studies revealed that relatively high concentrations of IL7 (10 ng/ml or greater) were required to stimulate IL6 production by monorytes (Fig. 2) . In contrast, we have previously shown that far lower concentrations of IL7 (0.1-1 ng/ml) will enhance human T cell proliferation and the generation of CTL in MLC (21, 23) . The relatively high concentrations of IL7 required to stimulate monocytes compared to T cells might be explained on the basis ofthe particular receptors used by the different cell types. Both low and high affinity binding of 11,7 to its receptor have been described (25) . Alternatively, there may be differences in the post receptor signaling pathways used by monocytes and T cells . In support ofthis concept, we have recently shown that IL7 induces macrophage inflammatory protein-1(3 mRNA accumulation in human monorytes but not in purified T cells (S. IL-7, in addition to promoting IL6 production, induced the secretion of IL1a, ILl0, and TNF-a by peripheral blood monorytes. Thus, IL7 may have a very broad range of biological activities on the immune system, both directly and via the cascade of cytokines that it induces. At this time it is not clear whether the effect of 11,7 on the production of IL6 by monocytes is direct or mediated via a rytokine cascade. Conceivably, IL7 could function by inducing another rtokine, for example IL 1, which could then in turn induce IL6 secretion. However, we believe that this is unlikely since the kinetics of induction of 11,6 secretion by IL-7 and I1,10 are identical and because 11,7 is a more potent inducer of 11,6 secretion than either IL1a or IL1a. We are currently investigating whether any of the effects of IL7 on monorytes are mediated via a rtokine cascade using neutralizing antibodies against IL1ci, ILl0, and TNF-a.
Previous studies have demonstrated that IL4 inhibits IL1, IL-6, and TNF gene expression and protein secretion induced by mitogenic stimuli such as LPS (4, 8, 9, (14) (15) (16) (17) . In this paper we extend these previous findings to show that IL4 also inhibits the ability of IL7 to induce monoryte cytokine synthesis at both the mRNA and protein levels. Thus, our data suggest that IL4 may be an important regulator of inffam- (23, 27) . Collectively, these data suggest that 11,4 plays a central role in down regulating multiple facets of the immune response. Whether the ability of IL4 to downregulate LAK cell induction and CTL generation is linked to its ability to inhibit cytokine secretion by monocytes remains to be elucidated. Incubation of monocytes with IL7 resulted in the activation of tumoricidal activity against the A375 melanoma cell line (Table 5) . Monocyte/macrophage tumoricidal activity is thought to be mediated, at least in part, by the secretion of soluble mediators such as TNF-a and 111 (35) (36) (37) , though cell-cell contact may be involved (38, 39) . Therefore, the ability of 11,7 to induce monocyte/macrophage tumoricidal activity correlates well with its ability to induce Ma, IL10, and TNF-a secretion by monocytes ( Table 4 ). As such, IL7joins GM-CSF as a rytokine that may be potentially useful for activating monocytes in vivo to become lytic against certain tumors .
In an attempt to more closely mimick the complexity of in vivo conditions, we used the recently describedwholeblood culture system (32, 33) and found that both IL-7 and 11,1/3 induced IL6 secretion that was detectable in the plasma within 24 h of stimulation. Thus, monocytes derived from circulation, exposed to either IIr1 or IL7 in vivo, could conceivably contribute to the elevated levels of serum IL6 observed after various challenges to the immune system (40) (41) (42) .
Whether 11,7 plays a role in the inflammatory immune response in vivo via the production of IL6, 11,1a, ID10, and TNF-a remains to be elucidated . However, our monocyte data generated in vitro and results using whole blood cultures suggest this is a distinct possibility, providing that monocytes are exposed to the appropriate concentration of IL7 in vivo. Localized environments in vivo, such as the bone marrow or thymus where IL7 appears to be constitutively produced (18) , may provide the appropriate IL7 concentrations . Thus, inhibitors of the effects of IL7 on monocytes, such as IL4 or the naturally occurring soluble version of the I1,7 receptor (43), may prove to be useful therapeutically to regulate inflammatory immune responses .
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